Sebastian A. Brunemeier Email & Phone Number

United Arab Emirates

US, Oxford UK & Lausanne CH

Drug discovery platform for immune system rejuvenation. ImmuneAGE.bio

United States

Advancing the field of Longevity Biotech (LongBio). Launching soon!

San Francisco

Venture fund focused on longevity biotech ("LongBio") & geroscience.

San Francisco, California, United States

Geneva, Switzerland

Switzerland

Financing longevity biotech ("LongBio") and academic partnerships via a decentralized autonomous organization. https://www.vitadao.com/

Global

Prizes for novel ideas in the geroscience & LongBio fields. Supported by Foresight Institute, VitaDAO, LEAF, etc. https://www.longevityprize.com/

Zurich, Switzerland

The world's leading longevity clinic. In stealth mode

Switzerland

A decentralized stock exchange and licensing platform for biotech intellectual property. Originators of the VitaDAO decentralized financing platform for longevity biotech.

Chapel Hill, North Carolina, United States

Revivo Therapeutics is clinical-stage pharmaceutical company developing a new class of cognitive-enhancing small molecules: nomethiazoles, which act as nitric oxide donor prodrugs and GABA(A) positive allosteric modulators. This results in CREB activation, vasodilation, reduced neuroinflammation, and reduced excitotoxicity. This MoA is neuroprotective in.

San Francisco

Developing safe mitochondrial uncoupling drugs for metabolic health and longevity. A spinout of UCSF and Y Combinator. Key paper: Bertholet & Kirichok 2019 in Nature.

Oxford, United Kingdom

Samsara Therapeutics, Inc. is biopharmaceutical platform company aiming to discover first-in-class therapeutics that extend healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend healthy lifespan and enhance autophagy. Samsara Therapeutics is a global.

Investing in biotech and health tech. Feel free to send me your pitch deck:-) https://www.picuscap.com/

Helping build a community of biotech founders in the 'LongBio' sector. Launched by Nathan Cheng (See: longevitylist.com). https://beondeck.com/longevity-biotech

Global

Advising the pharma practice (PMP) and McKinsey Global Institute.

New York City

Cambrian Biopharma is a biotech venture capital holding company that helps scientists transmit their discoveries from the lab into the clinic. Cambrian has raised ±$150M since founding, with >10 subsidiaries. Cambrian is uniquely focused on a specific field of biomedical research: the biology of aging, also known as geroscience. Cambrian is built on an.

La Jolla (San Diego)

"Black belt chemistry" on natural products targeting the biology of aging and proteostasis. Currently in stealth mode. A spinout of The Scripps Research Institute. A portfolio company of Cambrian Biopharma.

Hamburg Area, Germany

Apollo Ventures is a life science venture capital firm and company builder working across Europe and North America, with >$200M in funds raised across two transatlantic funds. Apollo is unique among venture funds due to its focus on a specific field of scientific research – the biology of aging.apollo.vc

London, United Kingdom

Deep Knowledge Ventures (DKV) is a London and Hong Kong-based venture firm focused on disruptive technology. Deep Knowledge Life Sciences (DKLS) is a London-based DKV subsidiary focused on biotechnology and regenerative medicine. The firm is now known as Longevity.Capital.

Lisbon, Portugal

Fulbright fellowship to conduct research on the genetics of aging -- cellular senescence, telomere dynamics, and genomic instability at the Instituto Gulbenkian de Ciencia (IGC) in the laboratory of Dr. Miguel Godinho Ferreira (HHMI investigator).

Irvine, CA

As an early employee, I wore several hats. I left for a Fulbright fellowship.

Pasadena, CA

Biotechnology venture capital economics research, including research on the dynamics of venture-backed IPOs. Left to help launch Pascal Chemistry.

Novato, CA

Project on neuropeptides and aging in C. elegans. Funded by the SENS Research Foundation.

New York City

In the lab of Dr. John H. Morrison, Dean of the Graduate School of Biomedical Sciences and Professor of Neuroscience. Excitatory glutamatergic AMPA receptors are the most common membrane-bound receptor in the central nervous system. They and the NMDA receptors are central to long-term potentiation, memory, and mechanisms of neurodegeneration. The AMPA.

Phd (Dphil) Studies (Abd), Biochemistry Of Aging. Clarendon Scholarship

Activities and Societies: Clarendon Scholar. Lincoln College. Unfinished ("all but dissertation"), dropped out to co-found Cambrian.

Skaggs-Oxford Scholar Fellowship (Joint Phd Program With Oxford, Awarded But Paused), Dept Of Molecular Medicine

Activities and Societies: Highly selective joint PhD/DPhil program between Scripps and Oxford. The only joint degree program in Oxford's.

Msc, Biomedical Science (Molecular Neuroscience), Cum Laude

Activities and Societies: Amsterdam Excellence Scholarship. UvA is the #1 ranked and largest university in the Netherlands. Coursework.

Masters Of Business Management (Joint Msc W Uva), Life Science Business Management, Cum Laude (Top 10%)

Thesis: "Evaluating Preclinical Drug Discovery Programs for Venture Capital: A Quantitative Model" Coursework: - Finance for Life Sciences.

Bachelor'S, Human Biology (Honors), 3.85/4.00 (Magna Cum Laude, Full Scholarship)

Activities and Societies: Vice President of Student Senate, College Budgetary Implementation Committee, Trustee Endowment & Investment.

Fulbright Fellowship, Telomere Biology & Cellular Senescence

Fulbright Fellowship in the lab of Miguel Godinho Ferreira, working on telomere biology and senescence in Zebrafish at the Gulbenkian.

Honors Undergrad Thesis

Activities and Societies: John Morrison lab. Focused on AMPA receptors in cognitive aging.